mRNA製造にテンプレートアプローチを適用し、堅牢で柔軟なプロセスを実現
mRNA革命の準備はできていますか?バイオ医薬品会社が実証済みの戦略を適用して、mRNA製造における隠れた複雑さを克服する方法についてご紹介します。mRNA製造のあらゆる側面に対応するSU施設の迅速な設計と構築に役立つソリューションをご覧ください。
【学習内容】
- mRNA開発と製造における主な動向と課題
- ザルトリウスの技術と専門知識が、mRNA製造のすべてのステップでどのように役立つか。
- SU mRNAファシリティを迅速に設計・構築するための戦略とソリューション
スピーカー紹介
Ganesh Kumar
MS, Integrated Solutions Manager, Sartorius
Ganesh started at Sartorius in 2016 as a Process Engineer | Consultant and was one of the key contributors to the development of the conceptual design platform to design end-to-end process platforms in SU facilities. Today he fills the role of Integrated Solutions Manager. As part of the Integrated Solutions team at Sartorius,
he actively works with clients to conceptualize, design, and deliver process solutions and platforms at clinical | commercial manufacturing stage for production of protein-based and cell | gene-based therapies. He holds a Master of Science in Bioprocess Engineering from Technical University Hamburg-Harburg, Germany. Ganesh started his career at Lonza, Singapore, where he was actively involved in the tech transfer, validation, and large-scale commercial manufacturing of blockbuster mAbs. Over the years, he has actively collaborated|led projects on process positioning, acquisitions, building the technical platform, solution packages and establishing strategic customer collaborations for process intensification. He has over nine years of experience in the biopharmaceutical industry, both as an end-user and a solution provider. He is based in Göttingen, Germany.
Nargisse El Hajjami
Process Technology Manager mRNA
Nargisse El Hajjami joined Sartorius in 2022 as Global mRNA Process Technology Manager. She holds a master’s degree in biotechnology and bioengineering and a PhD in biomedical and pharmaceutical sciences from the Université libre de Bruxelles in Brussels, Belgium. She has 12 years’ experience combining scientific research, process development, biomanufacturing engineering, and business development.